Travere Therapeutics to Present New FILSPARI® (sparsentan) Data at the 15th International Podocyte Conference

Travere Therapeutics announced it will present new data on FILSPARI (sparsentan) at the International Podocyte Conference. Data from the Phase 2 SPAR...
Home/KnloSights/Clinical Trial Updates/Travere Therapeutics to Present New FILSPARI® (sparsentan) Data at the 15th International Podocyte Conference